Keyword: Cold Spring Harbor Laboratory
Several cancer drug candidates are designed to kill tumor cells by attacking certain targets, but they work in other ways, researchers found.
Targeting CA19-9, a biomarker that's been used to assess pancreatic disease burden, may help treat pancreatic cancer, scientists found.
Inhibiting the PHLPP2 phosphatase enzyme could be an efficient way to suppress MYC-driven prostate cancer, scientists found.
Instead of seeking the underlying cause of a group of symptoms, scientists started with a mutation and then tracked down people who have it.
PTEN is often called an “anticancer” protein, because it prevents tumor cells from growing out of control. Scientists at Cold Spring Harbor Laboratory have discovered that another protein protects PTEN, and that a deficiency in this protective mechanism could be the driving force behind some cases of prostate cancer, lung cancer and other tumor types.
Scientists at Cold Spring Harbor Laboratory in New York have created the first model of genetic obesity in fruit flies.
A team of researchers at Long Island, NY’s Cold Spring Harbor Laboratory have developed a brain mapping technique that can, in a single experiment, trace the paths of individual neurons like stepping stones from one to another.